In mice, FGF21 administration has been shown to increase fatty acid oxidation and lower blood glucose as well as triglyceride levels protecting animals from diet induced obesity and diabetes [25,26]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.